Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
$0.43
-2.3%
$0.99
$0.29
$3.53
$65.20M2.2440.49 million shs1.51 million shs
Lifevantage Corporation stock logo
LFVN
Lifevantage
$5.02
-16.3%
$4.71
$3.90
$15.00
$76.83M0.52248,333 shs485,440 shs
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$0.78
-3.6%
$0.92
$0.74
$2.10
$31.92M1.65236,846 shs550,418 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
-3.74%-7.37%+22.89%-83.11%-78.21%
Lifevantage Corporation stock logo
LFVN
Lifevantage
+9.29%+18.81%+43.54%+29.87%-50.00%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-5.85%-9.99%-16.05%-19.00%-27.03%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
$0.43
-2.3%
$0.99
$0.29
$3.53
$65.20M2.2440.49 million shs1.51 million shs
Lifevantage Corporation stock logo
LFVN
Lifevantage
$5.02
-16.3%
$4.71
$3.90
$15.00
$76.83M0.52248,333 shs485,440 shs
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$0.78
-3.6%
$0.92
$0.74
$2.10
$31.92M1.65236,846 shs550,418 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
-3.74%-7.37%+22.89%-83.11%-78.21%
Lifevantage Corporation stock logo
LFVN
Lifevantage
+9.29%+18.81%+43.54%+29.87%-50.00%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-5.85%-9.99%-16.05%-19.00%-27.03%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
1.75
Reduce$5.501,171.97% Upside
Lifevantage Corporation stock logo
LFVN
Lifevantage
2.00
Hold$5.00-0.40% Downside
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
2.00
Hold$2.00156.08% Upside

Current Analyst Ratings Breakdown

Latest IMMP, RMTI, and LFVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
DowngradeBuyHold$5.00
5/4/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
DowngradeHold (C)Hold (C-)
4/21/2026
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
Reiterated RatingSell (D-)
3/30/2026
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
Lower Price TargetBuy$2.50 ➝ $2.00
3/27/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
Reiterated RatingHold (C)
3/13/2026
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
DowngradeBuyHold
3/13/2026
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
DowngradeOutperformNeutral$7.00 ➝ $1.00
3/13/2026
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
DowngradeOutperformMarket Perform
2/23/2026
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
Initiated CoverageMarket Outperform$10.00
2/17/2026
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
Initiated CoverageMarket Outperform$6.00
(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
$6.69M9.53N/AN/A$0.63 per share0.69
Lifevantage Corporation stock logo
LFVN
Lifevantage
$228.53M0.28$0.92 per share5.46$2.75 per share1.83
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$69.26M0.44N/AN/A$0.94 per share0.83
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
-$39.78MN/AN/AN/AN/AN/AN/AN/AN/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
$9.81M$0.6011.167.17N/A2.94%23.84%12.34%N/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$5.31M-$0.15N/A19.53N/A-7.67%-15.64%-9.61%5/7/2026 (Confirmed)

Latest IMMP, RMTI, and LFVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$0.01-$0.01N/A-$0.04$17.95 million$17.34 million
5/6/2026Q3 2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.16$0.12-$0.04$0.11$47.77 million$43.72 million
3/26/2026Q4 2025
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$0.04-$0.01-$0.05-$0.01$18.58 million$18.35 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
N/AN/AN/AN/AN/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.183.59%N/A30.00%3 Years
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
N/AN/AN/AN/AN/A

Latest IMMP, RMTI, and LFVN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
quarterly$0.054%6/1/20266/1/20266/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
N/A
2.97
N/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
N/A
2.03
1.03
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
0.25
3.98
3.63

Institutional Ownership

CompanyInstitutional Ownership
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
2.32%
Lifevantage Corporation stock logo
LFVN
Lifevantage
35.32%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
23.31%

Insider Ownership

CompanyInsider Ownership
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
3.07%
Lifevantage Corporation stock logo
LFVN
Lifevantage
21.95%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
3.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Prima BioMed Ltd stock logo
IMMP
Prima BioMed
2,021147.37 million142.85 millionOptionable
Lifevantage Corporation stock logo
LFVN
Lifevantage
26012.81 million9.99 millionOptionable
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
30039.40 million37.99 millionOptionable

Recent News About These Companies

Rockwell Medical, Inc. Q4 2025 Earnings Call Summary
Rockwell Medical Q4 Earnings Preview

New MarketBeat Followers Over Time

Media Sentiment Over Time

Prima BioMed stock logo

Prima BioMed NASDAQ:IMMP

$0.43 -0.01 (-2.26%)
Closing price 04:00 PM Eastern
Extended Trading
$0.43 -0.01 (-1.25%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Its LAG-3 immunotherapies are designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune disease. Its lead product candidate is eftilagimod alpha (efti or IMP321) for the treatment of different types of cancers. The trials that efi is being evaluated in include TACTI-002, a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC); TACTI-003, a Phase IIb clinical trial to treat HNSCC; and INSIGHT-003, a Phase I clinical trial for the treatment of NSCLC, as well as INSIGHT-005, a Phase I/IIa clinical trial to treat solid tumors. In addition, it offers IMP761, an agonist of lymphocyte activation gene 3 for autoimmune disease; IMP701, an antagonist antibody that acts to stimulate T cell proliferation in cancer patients; and IMP731, a depleting antibody that removes T cells involved in autoimmunity. The company has collaboration agreements with GlaxoSmithKline, Novartis, CYTLIMIC Inc., Merck & Co., Inc., Institute of Clinical Cancer Research, Merck KGaA, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is headquartered in Sydney, Australia.

Lifevantage stock logo

Lifevantage NASDAQ:LFVN

$5.02 -0.98 (-16.33%)
Closing price 04:00 PM Eastern
Extended Trading
$5.07 +0.05 (+1.08%)
As of 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

Rockwell Medical stock logo

Rockwell Medical NASDAQ:RMTI

$0.78 -0.03 (-3.58%)
Closing price 04:00 PM Eastern
Extended Trading
$0.79 +0.01 (+0.64%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.